Literature DB >> 9127164

ACOG educational bulletin. Seizure disorders in pregnancy. Number 231, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists.

.   

Abstract

With close cooperation and communication among the obstetrician, neurologist, pediatrician, and patient, most women with idiopathic epilepsy who become pregnant will have an uneventful pregnancy with an excellent outcome. To optimize the neonatal outcome in a patient requiring medication, using a single drug at the lowest possible dose that keeps her free of seizures is preferable. The prevention of tonic-clonic seizures, however, is of utmost importance. Simple interventions such as avoiding sleep deprivation, having the patients take folic acid before conception, and giving the infant a vitamin K injection at birth will help optimize the outcome. There is an increase of congenital malformations in infants born to women with epilepsy; however, the incidence is low. Most women with epilepsy will experience normal pregnancy and labor and will have spontaneous vaginal deliveries of healthy babies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127164

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  16 in total

1.  Managing women with epilepsy. Guideline producers now need to pay attention to implementation.

Authors:  S Wiebe
Journal:  BMJ       Date:  2000-01-01

2.  [Evaluation of folate substitution in women with epilepsy. Determination of erythrocyte folic acid concentrations].

Authors:  J Bauer; M Bös; J Rück; B Stoffel-Wagner
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

3.  In utero antiepileptic drug exposure: fetal death and malformations.

Authors:  K J Meador; G A Baker; R H Finnell; L A Kalayjian; J D Liporace; D W Loring; G Mawer; P B Pennell; J C Smith; M C Wolff
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

4.  Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United States.

Authors:  Sarah C MacDonald; Brian T Bateman; Thomas F McElrath; Sonia Hernández-Díaz
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

Review 5.  Antiepileptic drugs and neurodevelopment.

Authors:  Gholam K Motamedi; Kimford J Meador
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 6.  Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful?

Authors:  Naghme Adab
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Treatment of Neurocritical Care Emergencies in Pregnancy.

Authors:  Sangini S Sheth; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2012-02-02       Impact factor: 3.598

Review 8.  Treatment of epilepsy in pregnancy.

Authors:  I Nulman; D Laslo; G Koren
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 9.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care.

Authors:  Maria Muzik; Sheila M Marcus; Julie E Heringhausen; Heather Flynn
Journal:  Obstet Gynecol Clin North Am       Date:  2009-12       Impact factor: 2.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.